Gastric cancer is not a top10 malignancy in the United States but represents one of the
most common causes of cancer death worldwide. Biological differences between tumors …

Gastric cancer (GC) is one of the most common malignancies worldwide and it is the fourth
leading cause of cancer-related death. GC is a multifactorial disease, where both …

PURPOSE Gastric cancer (GC) with peritoneal metastases (PMs) is a poor prognostic
evolution. Cytoreductive surgery (CRS) yields promising results, but the impact of …

The authors focused on the current surgical treatment of resectable gastric cancer, and
significance of peri-and post-operative chemo or chemoradiation. Gastric cancer is the 4 th …

Peritoneal carcinomatosis (PC) is an important cause of morbidity and mortality among
patients with gastric cancer. The aim of the current study was to provide reliable population …

Background This randomized phase III study was to evaluate the efficacy and safety of
cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for …

Gastric cancer is the second most frequent cause of cancer death worldwide, although much
geographical variation in incidence exists. Prevention and personalised treatment are …

Several gastrointestinal and gynecological malignancies have the potential to disseminate
and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has …

Introduction An important component of treatment failure in gastric cancer (GC) is cancer
dissemination within the peritoneal cavity and nodal metastasis. Intraperitoneal …

Background A prospective randomized trial was conducted to compare the impact of
systemic chemotherapy versus multimodality therapy (complete cytoreductive surgery …